High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation

Blood

Volumn 91, Issue 9, 1998, Pages 3148-3155

  Ketterer, Nicolas ^b   Salles, Gilles ^a   Raba, Michel ^b   Espinouse, Daniel ^b   Sonet, Anne ^b   Tremisi, Pierre ^b   Dumontet, Charles ^b   Moullet, Isabelle ^b   Eljaafari Corbin, Assia ^b   Neidhardt Berard, Eve Marie ^b   Bouafia, Fadhela ^b   Coiffier, Bertrand ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0032079497     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3148.3148_3148_3155     Document Type: Article

References (36)

1. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van Der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540, 1995
2. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91, 1996
3. Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW, Wong RM, Brown BW, Blume KG: High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. Blood 89:801, 1997
4. Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F for the Groupe d'Etude des Lymphomes de l'Adulte: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. J Clin Oncol 15:1131, 1997
5. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290, 1997
6. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997
7. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Horwath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
8. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
9. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, Mc Grath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
10. Körbling M, Holle R, Haas R, Knauf W, Dörken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W: Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol 8:978, 1990
11. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
12. Langlands K, Craig JIO, Parker AC, Anthony RS: Molecular determination of minimal residual disease in peripheral blood stem cell harvests. Bone Marrow Transplant 5:64, 1990 (suppl 1)
13. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp DL, Dale BM, Dart GW, Roberts MM, Sage RE, Juttner CA: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442, 1990
14. Pierelli L, Iacone A, Quaglietta AM, Nicolucci A, Menichella G, Panici PB, D'Antonio D, De Laurenzi A, De Rosa L, Fioritoni G, Indovina A, Leone G, Majolino I, Montuoro A, Scimé R, Torlontano G: Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: A multicentre retrospective study. Br J Haematol 86:70, 1994
15. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Gregg A, Pillow A, Bolton A: Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11, 1992
16. Serke S, Arseniev L, Watts M, Fritsch G, Ingles-Esteve J, Johnsen HE, Linch D, Cancelas JA, Meyer O, Kadar JG, Huhn D, Matcham J: Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 20:57, 1997
17. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni M: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991
18. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994
19. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner D: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
20. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 19:303, 1997
21. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
22. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
23. + cell content. Bone Marrow Transplant 19:1103, 1997
24. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995
25. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
26. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM: Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 18:725, 1996
27. Pettengell R, Morgenstern GR, Woll PJ, Chang J, Rowlands M, Young R, Radford JA, Scarffe JH, Testa NG, Crowther D: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993
28. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995
29. + cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 13:1922, 1995
30. Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106, 1996
31. + cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. J Hematother 6:13, 1997
32. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994
33. + progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 86:4691, 1995
34. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood 89:1824, 1997
35. Domenech J, Gihana E, Dayan A, Truglio D, Linassier C, Desbois I, Lamagnere JP, Colombat P, Binet C: Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture. Br J Haematol 88:488, 1994
36. Voso MT, Murea S, Goldschmidt H, Hohaus S, Haas R: High-dose therapy with peripheral blood stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment. Br J Haematol 94:759, 1996